Cargando…
Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea
OBJECTIVES: Many countries have authorized the emergency use of oral antiviral agents for patients with mild-to-moderate cases of coronavirus disease 2019 (COVID-19). We assessed the cost-effectiveness of these agents for reducing the number of severe COVID-19 cases and the burden on Korea’s medical...
Autores principales: | Jo, Youngji, Kim, Sun Bean, Radnaabaatar, Munkhzul, Huh, Kyungmin, Yoo, Jin-Hong, Peck, Kyong Ran, Park, Hojun, Jung, Jaehun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Epidemiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350420/ https://www.ncbi.nlm.nih.gov/pubmed/35381167 http://dx.doi.org/10.4178/epih.e2022034 |
Ejemplares similares
-
Optimal Social Distancing Policy for COVID-19 Control in Korea: A Model-Based Analysis
por: Jo, Youngji, et al.
Publicado: (2022) -
Model-informed COVID-19 exit strategy with projections of SARS-CoV-2 infections generated by variants in the Republic of Korea
por: Jung, Sung-mok, et al.
Publicado: (2022) -
Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine
por: Huh, Kyungmin, et al.
Publicado: (2021) -
Nationwide Trends in Non-COVID-19 Infectious Disease Laboratory Tests in the Era of the COVID-19 Pandemic in Korea
por: Kim, Sun Bean, et al.
Publicado: (2023) -
Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of Korea
por: Yoon, Kyuhyun, et al.
Publicado: (2022)